Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid

Clodi, M; Abrahamian, H; Drexel, H; Fasching, P; Föger, B; Francesconi, C; Hoppichler, F; Kaser, S; Kautzky-Willer, A; Lechleitner, M; Ludvik, B; Prager, R; Fröhlich-Reiterer, E; Roden, M; Säly, C; Schernthaner, G; Sourij, H; Toplak, H; Wascher, TC; Weitgasser, R.
[Antihyperglycemic treatment guidelines for diabetes mellitus type 2].
Wien Klin Wochenschr. 2016; 128 Suppl 2(4):S45-S53
Web of Science PubMed FullText FullText_MUG

 

Autor/innen der Med Uni Graz:
Fröhlich-Reiterer Elke
Sourij Harald
Toplak Hermann
Wascher Thomas
Altmetrics:

Dimensions Citations:

Plum Analytics:
Abstract:
Hyperglycemia significantly contributes to micro- and macrovascular complications in patients with diabetes mellitus. While lifestyle interventions remain cornerstones of disease prevention and treatment, most patients with type 2 diabetes will eventually require pharmacotherapy for glycemic control. The definition of individual targets regarding optimal therapeutic efficacy and safety is of great importance. In this guideline we present the most current evidence-based best clinical practice data for healthcare professionals.
Find related publications in this database (using NLM MeSH Indexing)
Austria -
Diabetes Mellitus, Type 2 - diagnosis
Diabetes Mellitus, Type 2 - drug therapy
Diabetes Mellitus, Type 2 - prevention & control
Dose-Response Relationship, Drug -
Drug Administration Schedule -
Evidence-Based Medicine -
Humans -
Hyperglycemia - drug therapy
Hyperglycemia - prevention & control
Hypoglycemic Agents - administration & dosage
Practice Guidelines as Topic -
Treatment Outcome -

Find related publications in this database (Keywords)
Diabetes mellitus Type 2
Therapy
Glucose lowering
© Meduni Graz Impressum